Complications from Stereotactic Body Radiotherapy for Lung Cancer - Wikidata - awgldk - TriplyDB

Complications from Stereotactic Body Radiotherapy for Lung Cancer

Complications from Stereotactic Body Radiotherapy for Lung Cancer

http://www.wikidata.org/entity/Q26995851

about

Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review.Computed tomography-guided implantation of 125I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results.The Flaxseed-Derived Lignan Phenolic Secoisolariciresinol Diglucoside (SDG) Protects Non-Malignant Lung Cells from Radiation Damage Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases.Clinically relevant investigation of flattening filter-free skin dose.Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.Comparative efficacy and toxicity of induction chemotherapy with concurrent stereotactic body radiotherapy and stereotactic body radiotherapy with subsequent chemotherapy in patients with clinical stage T1-3N0M0 non-small cell lung carcinoma.Treatment-Related Adverse Effects in Lung Cancer Patients after Stereotactic Ablative Radiation Therapy Comparison of clinical efficacy and complications of I seed brachytherapy and stereotactic body radiation therapy for recurrent pulmonary metastases from colorectal carcinoma

P2860

Q30241812-04833DF9-3946-45A5-925E-CE9F95DD6183 Q33704932-1E35722B-D190-4657-B9D1-DD326FDFB49B Q36512362-995C5C09-1B80-43ED-A2B0-583EE0EC4A34 Q36625439-1BFDBF63-52DF-4D57-9937-4FCA81B5143A Q45048527-0C4BD164-4EF6-431C-A1BB-F07ACEDD98FB Q46541148-A1BA5058-A3AB-467E-88D4-B8E9603C3087 Q48316437-36B9E6F0-DF60-4CA1-98FA-B1F70E35A371 Q58584561-EEA583B2-A17A-4E7C-8EC3-D1F438938B20 Q58779755-7C7046B6-E8D8-4DDC-B0E1-A01008A5B910

P2860

Complications from Stereotactic Body Radiotherapy for Lung Cancer

http://www.wikidata.org/entity/Q26995851

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@ast

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@en

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@nl

type

label

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@ast

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@en

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@nl

prefLabel

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@ast

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@en

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@nl

P1433

Q26995851-1E554FFF-D15C-4765-88F8-91ABFB99C90A

P1476

Q26995851-5CBC2E8C-9C91-4FAC-9B14-CE9285F37CE2

P2093

Q26995851-000C94A9-E612-4A0E-9D9F-F2B8E4C00D6E

Q26995851-43CA249B-CA69-4843-A162-E86CA5B3C7B4

Q26995851-4508BEF4-77D3-47A4-B35A-E7AB47DA8FB5

Q26995851-6D8AAA39-882A-4685-B863-CFF1C2A719D5

Q26995851-818BE066-ADD9-4AE2-8CB3-67573657E5B2

Q26995851-83CD0F33-6D2E-4148-B2F1-C4C3EBD23B6F

Q26995851-E121A0DC-86D0-4D4C-AA27-929BF473D081

Q26995851-FB539B5E-3877-4AAC-89CF-23EEAD09F226

P2860

Q26995851-06A0EBE2-8779-49CF-B7DE-CF972DBE099E

Q26995851-0A8501E7-07FC-4858-99A8-76192BAF2B5B

Q26995851-0D291A7E-68C4-4D55-B0DF-1DA65971533C

Q26995851-0FBD5F3D-94F1-4838-9520-57AD9B4050A7

Q26995851-141B04D2-AECE-4C94-86B8-8D9CF1170203

Q26995851-14C6D9AB-42EA-46F0-853A-EC522C2F6D99

Q26995851-22B36C37-F801-45CA-B75A-582E09B40E96

Q26995851-2486D6F1-8854-4FF1-AD91-4DE12744A466

Q26995851-255C3C72-FA36-4A46-AC62-4FAFAC31FF6C

Q26995851-297BC13E-4521-4C58-B028-F28BE970C709

P304

Q26995851-9BE864F8-EF91-4E64-B6BD-ABE8C8C8DA99

P31

Q26995851-C962E5EC-82B0-48B5-9A99-DD94249D3119

P356

Q26995851-CE044783-F62A-420E-96FB-04619D1A9700

P407

Q26995851-72E87563-62EB-423E-B863-643A9805EFC3

P433

Q26995851-7F295E47-BCCC-4E8A-ACCF-6E8E9D527564

P478

Q26995851-8A38A2F8-CEA1-4183-A3AA-4C291BD583DC

P50

Q26995851-B482278F-941B-447E-BC1E-2B83054C5704

P577

Q26995851-B824AC6B-1964-49F4-BC0E-06DA567DD730

P5875

Q26995851-A3BBE114-19CC-4E06-9BDA-E5D91573712C

P698

Q26995851-039433FE-3AE2-4A28-B77B-4A0FED380B42

P921

Q26995851-F484821F-7B2A-4D56-80EA-7A1F7EB9BCD6

P932

Q26995851-666ECE54-3090-41FA-86A4-811C8DEEBC59

P356

P1433

P1476

Complications from Stereotactic Body Radiotherapy for Lung Cancer

@en

P2093

Christian Okoye

http://www.w3.org/2001/XMLSchema#string

Kylie Kang

http://www.w3.org/2001/XMLSchema#string

Min Yao

http://www.w3.org/2001/XMLSchema#string

Ravi Patel

http://www.w3.org/2001/XMLSchema#string

Rodney Ellis

http://www.w3.org/2001/XMLSchema#string

Shankar Siva

http://www.w3.org/2001/XMLSchema#string

Simon Lo

http://www.w3.org/2001/XMLSchema#string

Tithi Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy

Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.

Four-dimensional stereotactic radiotherapy for early stage non-small cell lung cancer: a comparative planning study.

Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?

No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236

Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy.

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy

Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy.

Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.

P304

981-1004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS7020820

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Machtay

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278792526

http://www.w3.org/2001/XMLSchema#string

P698

26083933

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4491695

http://www.w3.org/2001/XMLSchema#string